Nautilus Biotechnolgy, Inc.(NAUT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NAUT Nautilus Biotechnolgy, Inc.

交易中 06-29 13:37:15 EDT

1.81

-0.19

-9.49%

最高2.07	最低1.71	成交量139.14万
今开2.05	昨收2.00	日振幅18.00%
总市值2.30亿	流通市值8,378万	总股本1.27亿
成交额256.21万	换手率3.01%	流通股本4,628万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NAUT","market":"US","secType":"STK","nameCN":"Nautilus Biotechnolgy, Inc.","latestPrice":1.8103,"timestamp":1782754623552,"preClose":2,"halted":0,"volume":1391383,"delay":0,"changeRate":-0.09484999999999999,"floatShares":46279068,"shares":127078855,"eps":-0.451696,"marketStatus":"交易中","change":-0.1897,"latestTime":"06-29 13:37:15 EDT","open":2.05,"high":2.07,"low":1.71,"amount":2562120.2055834,"amplitude":0.18,"askPrice":1.82,"askSize":2305,"bidPrice":1.81,"bidSize":2592,"shortable":0,"etf":0,"ttmEps":-0.451696,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1782763200000},"marketStatusCode":2,"adr":0,"listingDate":1596772800000,"exchange":"NASDAQ","adjPreClose":2,"preHourTrading":{"tag":"盘前","latestPrice":2.11,"preClose":2,"latestTime":"09:29 EDT","volume":2299,"amount":4898.3726264,"timestamp":1782739741290,"change":0.11,"changeRate":0.055,"amplitude":0.125},"postHourTrading":{"tag":"盘后","latestPrice":2.07,"preClose":2,"latestTime":"19:44 EDT","volume":239813,"amount":479744.22,"timestamp":1782517441956,"change":0.07,"changeRate":0.035,"amplitude":0.03575},"volumeRatio":1.162852,"impliedVol":0.8676,"impliedVolPercentile":0.1673},"requestUrl":"/m/hq/s/NAUT/wiki","defaultTab":"wiki","newsList":[{"id":"2617591395","title":"Nautilus Biotechnology, Inc.盘中异动 大幅上涨5.39%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617591395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617591395?lang=zh_cn&edition=full","pubTime":"2026-03-04 23:05","pubTimestamp":1772636732,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日23时05分，Nautilus Biotechnology, Inc.股票出现异动，股价大幅拉升5.39%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Can Fite Biopharma Ltd、Scisparc Ltd.、Dianthus Therapeutics, Inc.涨幅较大，Can Fite Biopharma Ltd、Klotho Neurosciences, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为2160.20%、52.94%、40.78%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Can Fite Biopharma Ltd、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为51.24%、41.60%、39.80%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304230532a44bca35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304230532a44bca35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103139468","title":"Nautilus Biotechnology, Inc. 预计2026年运营支出将较2025年增长约15%至20%——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1103139468","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103139468?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:27","pubTimestamp":1772105269,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的最新文件，生物技术公司Nautilus Biotechnology, Inc. 对其未来财务支出作出预测。公司预计，在2026财年，其运营支出将呈现显著上升趋势，同比2025年增幅大约在15%到20%之间。\n这一预测揭示了公司在推进其生物技术研发和商业拓展过程中可能面临的成本增长。运营费用的增加通常关联于研发投入的加大、人才团队的扩充以及市场拓展活动的加强，这也从侧面反映了公司对未来业务发展的积极规划与投入决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156971400","title":"Nautilus Biotechnology Inc. 2026年早期访问项目预计不会带来实质性收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1156971400","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156971400?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:22","pubTimestamp":1772104971,"startTime":"0","endTime":"0","summary":"Nautilus Biotechnology Inc. 近日表示，公司在2026年之前预计不会从早期访问项目合作中获得实质性收入。这一声明揭示了公司商业化进程的阶段性特征，同时也反映出生物科技企业在产品市场化初期普遍面临的营收挑战。作为专注于蛋白质组学技术开发的创新企业，Nautilus目前仍处于技术验证和平台优化阶段。随着蛋白质组学技术在药物研发、疾病诊断等领域的应用价值日益凸显，Nautilus所专注的技术方向具备广阔的市场前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612494425","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612494425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612494425?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:57","pubTimestamp":1771426665,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时57分，Nautilus Biotechnology, Inc.股票出现波动，股价大幅拉升5.39%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218225745a4b09ef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218225745a4b09ef4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609926103","title":"Nautilus Biotechnology, Inc.盘中异动 股价大跌5.14%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609926103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609926103?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:58","pubTimestamp":1770217094,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日22时58分，Nautilus Biotechnology, Inc.股票出现异动，股价大幅跳水5.14%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Liminatus Pharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Gri Bio, Inc.、Evogene Ltd.较为活跃，换手率分别为375.40%、195.61%、106.95%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Liminatus Pharma, Inc.，振幅分别为61.25%、33.87%、31.77%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204225814a47c64d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204225814a47c64d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518277937","title":"Nautilus Biotechnology, Inc.盘中异动 快速跳水5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518277937?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:12","pubTimestamp":1741623169,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时12分，Nautilus Biotechnology, Inc.股票出现异动，股价快速下挫5.33%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3682.99%、3106.33%、934.80%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100124996405771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100124996405771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517458105","title":"Nautilus Biotechnology, Inc.2024财年实现净利润-70.78百万美元，同比减少11.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517458105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517458105?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363244,"startTime":"0","endTime":"0","summary":"3月8日，Nautilus Biotechnology, Inc.公布财报，公告显示公司2024财年净利润为-70.78百万美元，同比减少11.15%；其中营业收入为0.00美元，每股基本收益为-0.56美元。机构评级：截至2025年3月8日，当前有3家机构对Nautilus Biotechnology, Inc.目标价做出预测，其中目标均价为2.17美元，其中最低目标价为1.00美元，最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000140a2647ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000140a2647ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517928381","title":"Nautilus Biotechnology, Inc.盘中异动 下午盘快速下跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517928381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517928381?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:36","pubTimestamp":1741289806,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时36分，Nautilus Biotechnology, Inc.股票出现波动，股价快速跳水5.00%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033646989ee927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033646989ee927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514320017","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨6.41%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320017?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:35","pubTimestamp":1740753312,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分，Nautilus Biotechnology, Inc.股票出现异动，股价大幅上涨6.41%。截至发稿，该股报1.25美元/股，成交量6775股，换手率0.01%，振幅0.00%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223512a258022b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223512a258022b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4007","VRPX","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514386241","title":"Nautilus Biotechnology, Inc.盘中异动 股价大跌11.89%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386241?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:30","pubTimestamp":1740666624,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时30分，Nautilus Biotechnology, Inc.股票出现波动，股价快速下挫11.89%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722302498950fb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722302498950fb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAG","NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110538525","title":"鹦鹉螺生物科技第四季度GAAP每股收益$(0.14)优于预期$(0.16)","url":"https://stock-news.laohu8.com/highlight/detail?id=1110538525","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110538525?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:38","pubTimestamp":1740659934,"startTime":"0","endTime":"0","summary":"鹦鹉螺生物科技报告的季度每股亏损为$，比分析师普遍预期的$好12.5％，与去年同期持平。以上内容来自Benzinga Earnings专栏，原文如下：Nautilus Biotechnology  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 12.5 percent. This is unchanged from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹦鹉螺生物科技第四季度GAAP每股收益$(0.14)优于预期$(0.16)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511457979","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511457979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511457979?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:23","pubTimestamp":1739474607,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时23分，Nautilus Biotechnology, Inc.股票出现波动，股价大幅拉升6.25%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.17%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3183.07%、1982.56%、1233.56%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214032327abcdeaee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214032327abcdeaee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510333685","title":"Nautilus Biotechnology, Inc.盘中异动 急速下跌5.29%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510333685?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:44","pubTimestamp":1739288678,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时44分，Nautilus Biotechnology, Inc.股票出现波动，股价急速下挫5.29%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为1.83%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2717.08%、1094.41%、376.48%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为58.60%、57.43%、39.00%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234438abcb165a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234438abcb165a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4139","BK4121","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509729942","title":"Nautilus Biotechnology, Inc.盘中异动 大幅下跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509729942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509729942?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:48","pubTimestamp":1738946880,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时48分，Nautilus Biotechnology, Inc.股票出现异动，股价快速跳水5.29%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004801abc648bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004801abc648bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509783940","title":"Nautilus Biotechnology, Inc.盘中异动 下午盘股价大跌5.11%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509783940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509783940?lang=zh_cn&edition=full","pubTime":"2025-02-07 03:34","pubTimestamp":1738870499,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日03时34分，Nautilus Biotechnology, Inc.股票出现异动，股价大幅下跌5.11%。截至发稿，该股报1.67美元/股，成交量2.6171万股，换手率0.02%，振幅5.51%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207033459961a4495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207033459961a4495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4121","NAUT","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508574384","title":"Nautilus Biotechnology, Inc.盘中异动 快速拉升5.26%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508574384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508574384?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:44","pubTimestamp":1738680264,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时44分，Nautilus Biotechnology, Inc.股票出现波动，股价急速上涨5.26%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1175.87%、786.09%、195.17%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Azitra Inc、Invivyd, Inc.，振幅分别为40.00%、38.71%、29.25%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224426abc22ad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224426abc22ad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507419624","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507419624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507419624?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:53","pubTimestamp":1738248832,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时53分，Nautilus Biotechnology, Inc.股票出现波动，股价大幅拉升5.11%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为1188.13%、157.12%、135.06%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Kazia Therapeutics Limited、Alterity Therapeutics Limited，振幅分别为56.41%、41.30%、36.77%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302253529614401e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302253529614401e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506581472","title":"Nautilus Biotechnology, Inc.盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506581472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506581472?lang=zh_cn&edition=full","pubTime":"2025-01-28 04:04","pubTimestamp":1738008241,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日04时04分，Nautilus Biotechnology, Inc.股票出现异动，股价快速跳水5.73%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、Sellas Life Sciences Group, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2182.49%、1079.77%、269.15%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.60%、99.77%、65.16%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280404019612693f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280404019612693f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506281371","title":"Nautilus Biotechnology, Inc.盘中异动 临近收盘快速跳水5.00%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506281371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506281371?lang=zh_cn&edition=full","pubTime":"2025-01-25 04:56","pubTimestamp":1737752169,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日04时56分，Nautilus Biotechnology, Inc.股票出现异动，股价大幅下跌5.00%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Evaxion Biotech As、Pmgc Holdings Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4702.34%、2476.69%、1800.54%，振幅较大的相关个股有Neuphoria Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 、Evaxion Biotech As，振幅分别为261.67%、251.21%、137.09%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125045609960fc798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125045609960fc798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505277167","title":"Nautilus Biotechnology, Inc.盘中异动 早盘股价大涨5.18%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505277167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505277167?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:09","pubTimestamp":1737472183,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时09分，Nautilus Biotechnology, Inc.股票出现波动，股价快速拉升5.18%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为689.66%、202.51%、171.30%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation，振幅分别为92.63%、38.48%、22.36%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230943986e3ac5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230943986e3ac5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nautilus.bio","stockEarnings":[{"period":"1week","weight":-0.1228},{"period":"1month","weight":-0.2188},{"period":"3month","weight":-0.4253},{"period":"6month","weight":0.0101},{"period":"1year","weight":1.4783},{"period":"ytd","weight":0.0256}],"compareEarnings":[{"period":"1week","weight":-0.0238},{"period":"1month","weight":-0.0286},{"period":"3month","weight":0.1497},{"period":"6month","weight":0.056},{"period":"1year","weight":0.1914},{"period":"ytd","weight":0.069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nautilus Biotechnology, Inc.于2020年3月27日在开曼群岛注册成立，是一家豁免公司，并于2021年6月8日在特拉华州重新注册成立。他们是一家处于发展阶段的生命科学公司，致力于创建用于量化和解锁人类蛋白质组复杂性的平台技术。他们的使命是通过使蛋白质组的访问民主化并实现人类健康和医学的根本进步来改变蛋白质组学领域。他们认为，现有技术的渐进式进步是不够的，需要进行大胆的科学飞跃才能彻底改造蛋白质组学并彻底改变精准医学。他们的愿景是整合他们在计算机科学、工程和生物化学方面的突破性创新，以开发和商业化具有极高灵敏度和规模的蛋白质组学分析技术。为了实现这一目标，他们建立了一个单分子仪器的原型，即他们的蛋白质组学分析系统，该系统将得到进一步开发，以提供他们认为建立新的黄金标准所必需的速度、简单性、准确性和多功能性场地。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.028311},{"month":2,"riseRate":0.666667,"avgChangeRate":0.077747},{"month":3,"riseRate":0.666667,"avgChangeRate":0.104644},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.140189},{"month":5,"riseRate":0.666667,"avgChangeRate":0.004324},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.06377},{"month":7,"riseRate":0.6,"avgChangeRate":-0.017062},{"month":8,"riseRate":0.2,"avgChangeRate":-0.079652},{"month":9,"riseRate":0.5,"avgChangeRate":0.010868},{"month":10,"riseRate":0.333333,"avgChangeRate":0.046365},{"month":11,"riseRate":0.5,"avgChangeRate":0.048822},{"month":12,"riseRate":0.5,"avgChangeRate":-0.033204}],"exchange":"NASDAQ","name":"Nautilus Biotechnolgy, Inc.","nameEN":"Nautilus Biotechnolgy, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nautilus Biotechnolgy, Inc.(NAUT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nautilus Biotechnolgy, Inc.(NAUT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nautilus Biotechnolgy, Inc.,NAUT,Nautilus Biotechnolgy, Inc.股票,Nautilus Biotechnolgy, Inc.股票老虎,Nautilus Biotechnolgy, Inc.股票老虎国际,Nautilus Biotechnolgy, Inc.行情,Nautilus Biotechnolgy, Inc.股票行情,Nautilus Biotechnolgy, Inc.股价,Nautilus Biotechnolgy, Inc.股市,Nautilus Biotechnolgy, Inc.股票价格,Nautilus Biotechnolgy, Inc.股票交易,Nautilus Biotechnolgy, Inc.股票购买,Nautilus Biotechnolgy, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nautilus Biotechnolgy, Inc.(NAUT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nautilus Biotechnolgy, Inc.(NAUT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}